# The Prognostic Impact of Selenium On Critical Surgical Patients

> **NCT04662242** · PHASE4 · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 36 (actual)

## Conditions studied

- Critical Illness
- Selenium Deficiency
- Trace Element Deficiency
- Acute Abdomen
- Sepsis

## Interventions

- **DRUG:** Selenium Supplement
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT04662242
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-01
- **Primary completion:** 2022-10-31
- **Final completion:** 2022-11-16
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04662242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04662242, "The Prognostic Impact of Selenium On Critical Surgical Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04662242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*